Philip M. Parker

Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows

Retrieved on: 
Sunday, February 11, 2024
Practice Management, Technology, Managed Care, Health, Radiology, Oncology, Health Technology, Software, Artificial Intelligence, Hospitals, Networks, Partnership, Safety, Icon, Radiation, Philip M. Parker, Research, Cancer, Medical imaging

Radformation , a global pioneer in radiation oncology software solutions, is pleased to announce its strategic partnership with Icon Group (Icon), a worldwide leader in comprehensive cancer care.

Key Points: 
  • Radformation , a global pioneer in radiation oncology software solutions, is pleased to announce its strategic partnership with Icon Group (Icon), a worldwide leader in comprehensive cancer care.
  • This collaboration unites the expertise of two innovators, setting the stage to significantly transform cancer care through groundbreaking workflows and advanced software solutions.
  • Icon is globally recognised for its unwavering commitment to providing exceptional end-to-end cancer treatment and patient care.
  • Together, we have the opportunity to improve the way cancer treatment is delivered and further empower clinicians in their mission to save lives."

Icon Group and Varian Collaborate on an International HyperArc Registry to Advance Treatment of Brain Tumors

Retrieved on: 
Monday, September 26, 2022
ACT, Siemens Healthineers, Group, Radiation, Gold Coast Private Hospital, Twitter, Machine learning, Brain, Icon, Neoplasm, LinkedIn, Partnership, Gold Coast University Hospital, Patient, History, Cancer, Physician, Thought, Birmingham, Technology, Quality of life, Solution, Philip M. Parker, Artificial intelligence, A Call for Unity, Associate, Radiation therapy, Research, Pharmacy, PALO, Overalls, University, Principal investigator, Toxicity, Medical imaging, Pharmaceutical industry, Varian

PALO ALTO, Calif. and SYDNEY, Sept. 26, 2022 /PRNewswire/ -- This World Cancer Research Day, Icon Group (Icon) becomes the first international participant in the HyperArc® registry, which is sponsored by Varian, a Siemens Healthineers company (Varian). HyperArc technology allows clinicians to treat tumors with highly conformal doses of radiation therapy. The automated system can even target several tumors in different locations in the brain. The Hyperarc registry will collect patient data for clinical research that will be used to inform and expand treatment options for patients with brain tumors.

Key Points: 
  • PALO ALTO, Calif. and SYDNEY, Sept. 26, 2022 /PRNewswire/ -- This World Cancer Research Day, Icon Group (Icon) becomes the first international participant in the HyperArc registry, which is sponsored by Varian, a Siemens Healthineers company (Varian).
  • The Hyperarc registry will collect patient data for clinical research that will be used to inform and expand treatment options for patients with brain tumors.
  • The HyperArc registry will contain data collectedduring and after the course of radiation treatment using HyperArc on a Varian linear accelerator.
  • The HyperArc registry will enable Icon to collaborate with other institutions, such as the University of Alabama at Birmingham, which is another key participant in the HyperArc registry.

HEAL Partners announces Strategic Relationship with Elliott Investment Management and launches US$500m Growth Fund II - closes Fund I heavily oversubscribed

Retrieved on: 
Tuesday, April 5, 2022
Chronic Fatigue Syndrome Advisory Committee, HEAL, Mary Stuart Gile, Former, Investment, Multimedia, ESG, Health and Education for All, IVF, Philip M. Parker, View, Lifestyle, Foundation, 100 Women in Hedge Funds, Elliott Management Corporation, Acceleration, Founder, Education, Renewable energy, Health

SYDNEY, April 5, 2022 /PRNewswire/ -- HEAL Partners, an Australia and Cayman based global Growth and Follow-On Fund specialising in Health, Education and Lifestyle sector investments ("HEAL"), today announced it has signed a Strategic Relationship Agreement with affiliates of Elliott Investment Management L.P. ("Elliott").

Key Points: 
  • SYDNEY, April 5, 2022 /PRNewswire/ -- HEAL Partners, an Australia and Cayman based global Growth and Follow-On Fund specialising in Health, Education and Lifestyle sector investments ("HEAL"), today announced it has signed a Strategic Relationship Agreement with affiliates of Elliott Investment Management L.P. ("Elliott").
  • As part of the Strategic Relationship, Elliott is expected to contribute a significant anchor commitment to HEAL's Fund II.
  • This Strategic Relationship follows Elliott's January 2021 investment in Removery, the world's largest tattoo removal business and a HEAL portfolio company founded by HEAL Partners' Mark Evans, Chris Chambers and Peter Chapman.
  • Its flagship fund, Elliott Associates, L.P., was founded in 1977, making it one of the oldest funds under continuous management.

HEAL Partners announces Strategic Relationship With Elliott Investment Management and Launches US$500m Growth Fund II – Closes Fund I Heavily Oversubscribed

Retrieved on: 
Tuesday, April 5, 2022
Professional Services, Education, Health, Other Education, Consulting, General Health, Defense Department Advisory Committee on Women in the Services, HEAL, Mary Stuart Gile, Former, Investment, ESG, Health and Education for All, IVF, Philip M. Parker, Lifestyle, Foundation, 100 Women in Hedge Funds, Elliott Management Corporation, Acceleration, Founder, Education, Renewable energy, Health

HEAL Partners, an Australia and Cayman based global Growth and Follow-On Fund specialising in Health, Education and Lifestyle sector investments (HEAL), today announced it has signed a Strategic Relationship Agreement with affiliates of Elliott Investment Management L.P. (Elliott).

Key Points: 
  • HEAL Partners, an Australia and Cayman based global Growth and Follow-On Fund specialising in Health, Education and Lifestyle sector investments (HEAL), today announced it has signed a Strategic Relationship Agreement with affiliates of Elliott Investment Management L.P. (Elliott).
  • As part of the Strategic Relationship, Elliott is expected to contribute a significant anchor commitment to HEALs Fund II.
  • This Strategic Relationship follows Elliotts January 2021 investment in Removery, the worlds largest tattoo removal business and a HEAL portfolio company founded by HEAL Partners Mark Evans, Chris Chambers and Peter Chapman.
  • On behalf of Elliott, Isaac Kim said, We are pleased about this Strategic Relationship with the HEAL team.

GenesisCare Appoints New Executive Manager Furthering Rapid Growth & Acquisitions

Retrieved on: 
Wednesday, February 23, 2022
Biotechnology, Health, Oncology, Practice Management, Partnership, Physician, Growth, Cardiology, Oncology, Philip M. Parker, COVID-19, Ramsay Health Care, Medicine, OAM, Precision medicine, Multimedia, Leadership, Cancer, Radiation, Frenchs Forest, New South Wales, Patient, Technology, Research, Program, Surgical oncology, Hospital, Pharmaceutical industry, GenesisCare, NSW, Healthscope

Richard joins at an exciting time of rapid growth and expansion for GenesisCare in Australia.

Key Points: 
  • Richard joins at an exciting time of rapid growth and expansion for GenesisCare in Australia.
  • GenesisCares Global Chief Operating Officer, Michael OSullivan, said: Were delighted to welcome Richard as GenesisCares new Oncology Australia Executive Manager.
  • In the past six months, GenesisCare has opened three new integrated centres GenesisCare North Shore (NSW), GenesisCare Maitland (NSW), and GenesisCare Murdoch (WA) with Norwest Sydney (NSW) currently nearing completion.
  • Richard Lizzio, Executive Manager for Oncology Australia, GenesisCare
    Headquartered in Sydney, Australia, GenesisCare is a global healthcare company and one of the worlds largest integrated oncology organisations.

DAZN GROUP APPOINTS AVIV GILADI AS PRESIDENT, BROADCAST PARTNERSHIPS

Retrieved on: 
Tuesday, February 1, 2022
News, CEO, Leadership, Sport, Personal computer, Women's Tennis Association, WTA, Athlete, European Handball Federation, Philip M. Parker, Television, I, Tonya, Partnership, Channel 10, DAZN, EHF, DAZN Group, Channel, Extreme Sports Channel, History, Mark (given name), Tablet

LONDON, Feb. 1, 2022 /PRNewswire/ -- DAZN Group, the leading global sports entertainment company, has announced today that Aviv Giladi has been appointed as President of Broadcast Partnerships, to oversee all joint venture partnerships.

Key Points: 
  • LONDON, Feb. 1, 2022 /PRNewswire/ -- DAZN Group, the leading global sports entertainment company, has announced today that Aviv Giladi has been appointed as President of Broadcast Partnerships, to oversee all joint venture partnerships.
  • Aviv joins having served as Chairman and CEO of global film production companies AI Film Ltd. and British Icon Group.
  • Aviv Giladi added: "DAZN Group has a brilliant portfolio of strategic partnerships and I look forward to further enhancing the commercial opportunities and helping grow new audiences for sports around the world.
  • DAZN Group is home to DAZN, theleading global sportdestination, as well as the popular sport portal, DAZN News.

Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment

Retrieved on: 
Friday, November 19, 2021
Patient, Cancer, Radiology, Goldman Sachs, Technology, Industry, Morgan Stanley, PricewaterhouseCoopers, Philip M. Parker, EQT, NYSE, Google Images, Partnership, QIC, Group, GS, COVID-19, History, City, Private equity, Research, Investment, Deloitte, Radiation, Varian Medical Systems, KWM, LinkedIn, Pharmacy, Growth, APAC, Renewable energy, Security (finance), Pharmaceutical industry

BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.

Key Points: 
  • BRISBANE, Australia, Nov. 19, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.
  • The new investment will allow the Group to continue to further expand its successful model intoAsiaand deeper into the northern hemisphere.
  • Mark Middleton, global CEO Icon Group added: "Icon's commitment to innovation and the delivery of cancer care is limitless.
  • Now, we can drive the next phase of global growth and market leadership through further investment in critical infrastructure and cutting-edge technologies."

Investment Confidence in Icon Group to Drive Next Phase of Global Growth With EQT Infrastructure Investment

Retrieved on: 
Friday, November 19, 2021
Patient, Cancer, Radiology, Goldman Sachs, Technology, Industry, Morgan Stanley, PricewaterhouseCoopers, Philip M. Parker, EQT, NYSE, Google Images, Partnership, QIC, Group, GS, COVID-19, History, City, Private equity, Research, Investment, Deloitte, Radiation, Varian Medical Systems, KWM, LinkedIn, Pharmacy, Growth, APAC, Renewable energy, Security (finance), Pharmaceutical industry

BRISBANE, Australia, Nov. 18, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.

Key Points: 
  • BRISBANE, Australia, Nov. 18, 2021 /PRNewswire/ -- Icon Group has today announced it will enter the next phase of global expansion of its transformative integrated cancer care model following the investment of global investment organisation EQT.
  • The new investment will allow the Group to continue to further expand its successful model intoAsiaand deeper into the northern hemisphere.
  • Mark Middleton, global CEO Icon Group added: "Icon's commitment to innovation and the delivery of cancer care is limitless.
  • Now, we can drive the next phase of global growth and market leadership through further investment in critical infrastructure and cutting-edge technologies."

Icon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from Varian

Retrieved on: 
Thursday, August 5, 2021
OIS, Chief executive officer, Solution, Health, Australian Recording Industry Association, Radiation, Philip M. Parker, Machine learning, Surgical oncology, Icon, Software, Patient, Twitter, Cancer, Artificial intelligence, LILO (boot loader), Oncology, Siemens Healthineers, Asia-Pacific, Thought, LinkedIn, EPRO, Group, Medical device, Medical imaging

Australia's Icon Group will become the first in the world to deploy this new system, which is scheduled for release in Australia and other global sites in early 2022.

Key Points: 
  • Australia's Icon Group will become the first in the world to deploy this new system, which is scheduled for release in Australia and other global sites in early 2022.
  • After a successful deployment, the new ARIA system will serve as Icon's next-generation platform for enhancing clinical operations, and further deployments at other Icon sites will commence.
  • Mark Middleton, CEO, Icon Group, said, "Icon is delighted to once again be at the forefront of technology evolution alongside Varian.
  • ARIA is Varian's comprehensive oncology information system for managing clinical, administrative, and financial processes in comprehensive cancer treatment environments.